EFFECTS OF AN ALPHA-1-ADRENERGIC BLOCKER IN DIABETES MELLITUS

这项研究将确定一种α-1肾上腺素能阻滞剂的作用 尿白蛋白排泄率(UAER)作为潜在保护性指标的研究 非胰岛素依赖型糖尿病的降压药物治疗 (NIDDM)。柯克博士还将评估一种α-1肾上腺素能阻滞剂是否对 对NIDDM患者血糖控制和血脂谱的积极作用 糖尿病患者。这项研究将获得对差异的理解 血压、尿白蛋白排泄率、血糖控制和血脂的变化幅度 配置文件。

This study will determine the effects of an alpha-1-adrenergic blocker on the urinary albumin excretion ratio (UAER) as a potential protective antihypertensive agent in non-insulin dependent diabetes mellitus (NIDDM). Dr. Kirk will also assess if an alpha-1-adrenergic blocker has a positive effect on glycemic control and lipid profiles in NIDDM diabetics. This study will gain understanding of the differential magnitude of changes in blood pressure, UAER, glycemic control and lipid profiles.